Hemophilia A Drug Gets FDA Nod

(MedPage Today) -- SILVER SPRING, Md. -- A recombinant fusion drug combining the Factor VIII protein with a peptide to extend its lifetime in circulation has been approved for treating hemophilia A, the FDA said.
Source: MedPage Today Public Health - Category: American Health Source Type: news